Long Noncoding RNA


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
27 01 2021
Historique:
received: 01 12 2020
revised: 17 01 2021
accepted: 21 01 2021
entrez: 30 1 2021
pubmed: 31 1 2021
medline: 27 7 2021
Statut: epublish

Résumé

Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression, which play fundamental roles in cancer development. In this study, we found that

Identifiants

pubmed: 33514011
pii: genes12020182
doi: 10.3390/genes12020182
pmc: PMC7912412
pii:
doi:

Substances chimiques

Chemokine CCL2 0
HOXA11 protein, human 0
HOXB13 protein, human 0
Homeodomain Proteins 0
RNA, Long Noncoding 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Br J Cancer. 2016 Oct 25;115(9):1017-1023
pubmed: 27685444
Urol Int. 1992;48(1):25-30
pubmed: 1376010
Nat Genet. 2015 Nov;47(11):1346-51
pubmed: 26457646
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17093-8
pubmed: 17942676
Cancer Cell. 2004 Jun;5(6):607-16
pubmed: 15193263
J Mol Med (Berl). 2014 Aug;92(8):811-23
pubmed: 24996520
Exp Cell Res. 1999 Apr 10;248(1):1-9
pubmed: 10094807
J Cell Physiol. 2009 Jan;218(1):135-45
pubmed: 18756497
Cancers (Basel). 2017 Aug 23;9(9):
pubmed: 28832494
Clin Exp Metastasis. 2013 Jun;30(5):569-78
pubmed: 23242739
Med Sci Monit. 2017 Jul 13;23:3393-3403
pubmed: 28701685
Cell Rep. 2019 Apr 16;27(3):940-954.e6
pubmed: 30956133
J Natl Cancer Inst. 2010 Apr 21;102(8):522-8
pubmed: 20233997
Genes Dis. 2017 Jun;4(2):75-87
pubmed: 28798948
Mol Cancer. 2017 Apr 26;16(1):82
pubmed: 28441948
Clin Cancer Res. 2004 Dec 15;10(24):8501-11
pubmed: 15623631
J Cell Physiol. 2006 Aug;208(2):326-35
pubmed: 16642470
Int J Cancer. 2005 Apr 10;114(3):436-41
pubmed: 15551325
Annu Rev Pharmacol Toxicol. 2008;48:171-97
pubmed: 17883327
Onco Targets Ther. 2018 Jul 27;11:4387-4393
pubmed: 30100744
Crit Rev Oral Biol Med. 1999;10(1):79-98
pubmed: 10759428
Am J Physiol Cell Physiol. 2011 Jan;300(1):C146-54
pubmed: 20861463
Matrix Biol. 1994 Jan;14(1):31-40
pubmed: 8061918
Oncol Rep. 2005 Apr;13(4):721-6
pubmed: 15756448
Nat Cell Biol. 2018 Mar;20(3):332-343
pubmed: 29459780
Wiley Interdiscip Rev Dev Biol. 2013 Jan-Feb;2(1):31-45
pubmed: 23799629
Biomed Pharmacother. 2017 Aug;92:437-444
pubmed: 28558357
J Natl Cancer Inst. 1998 Jul 1;90(13):1000-8
pubmed: 9665149
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Prostate. 2020 Apr;80(5):388-398
pubmed: 31971633
Nat Rev Immunol. 2005 Jul;5(7):546-59
pubmed: 15965491
Nat Immunol. 2017 Aug 22;18(9):962-972
pubmed: 28829444
Cell. 2007 Jun 29;129(7):1311-23
pubmed: 17604720
Nat Rev Cancer. 2018 Sep;18(9):533-548
pubmed: 30002479
Oncogene. 2018 Jan 18;37(3):313-322
pubmed: 28925401
Tumour Biol. 2017 Oct;39(10):1010428317721440
pubmed: 29034803
Cancers (Basel). 2018 Jun 01;10(6):
pubmed: 29865211
Nat Rev Cancer. 2002 Feb;2(2):91-100
pubmed: 12635172
Nat Commun. 2014 Apr 07;5:3591
pubmed: 24710016
PLoS One. 2012;7(1):e29743
pubmed: 22235336
Cell Biol Int. 2014 Sep;38(9):1076-9
pubmed: 24798520
Cancer Res. 2017 Dec 1;77(23):6480-6488
pubmed: 29162616
Clin Chim Acta. 2017 Nov;474:165-170
pubmed: 28942241
Cancer Sci. 2018 Oct;109(10):3068-3079
pubmed: 30099826
J Biol Chem. 2003 Oct 3;278(40):39044-50
pubmed: 12885781
Nat Med. 2015 Nov;21(11):1253-61
pubmed: 26540387
Cancer Res. 2016 Nov 1;76(21):6299-6310
pubmed: 27651312
Signal Transduct Target Ther. 2019 Nov 29;4:51
pubmed: 31815008
Cold Spring Harb Perspect Biol. 2014 Aug 01;6(8):
pubmed: 25085913
J Hematol Oncol. 2017 Feb 23;10(1):57
pubmed: 28231804
Nat Commun. 2020 Feb 21;11(1):1000
pubmed: 32081859
Oncotarget. 2017 Mar 28;8(13):21861-21870
pubmed: 28423531
Oncogene. 2005 Jun 23;24(27):4462-71
pubmed: 15806155
Calcif Tissue Int. 1997 Sep;61(3):183-8
pubmed: 9262507
Thyroid. 1998 Aug;8(8):637-41
pubmed: 9737356
Int J Mol Sci. 2013 Nov 01;14(11):21727-40
pubmed: 24189220
Immune Netw. 2019 Feb 25;19(1):e4
pubmed: 30838159
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):329-35
pubmed: 16445654
Genom Data. 2016 May 26;9:7-9
pubmed: 27330995
J Clin Invest. 2016 Aug 1;126(8):2775-82
pubmed: 27479746
Oncogene. 2006 Mar 16;25(12):1733-42
pubmed: 16278676
Hum Cell. 2019 Oct;32(4):504-514
pubmed: 31493246
Oncotarget. 2017 Aug 3;8(41):70642-70652
pubmed: 29050308
Trends Cell Biol. 2015 Apr;25(4):234-40
pubmed: 25572304

Auteurs

Aya Misawa (A)

Department of Molecular Medicine and Anatomy, Nippon Medical School, 1-1-5 Sendagi, Tokyo 113-8602, Japan.

Yukihiro Kondo (Y)

Department of Urology, Nippon Medical School, 1-1-5 Sendagi, Tokyo 113-8602, Japan.

Hiroyuki Takei (H)

Department of Breast Surgical Oncology, Nippon Medical School, 1-1-5 Sendagi, Tokyo 113-8602, Japan.

Toshihiro Takizawa (T)

Department of Molecular Medicine and Anatomy, Nippon Medical School, 1-1-5 Sendagi, Tokyo 113-8602, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH